[1] Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies:a statement by the American Diabetes Association[J]. Diabetes Care, 2005, 28(4):956-962. [2] Hamid HS, Mervak CM, Münch AE, et al. Hyperglycemia-and neuropathy-induced changes in mitochondria within sensory nerves[J]. Ann Clin Transl Neurol,2014, 1(10):799-812. [3] Edwards JL, Vincent AM, Cheng HT, et al. Diabetic neuropathy:mechanisms to management[J]. Pharmacol Ther, 2008, 120(1):1-34. [4] Sandireddy R, Yerra VG, Areti A, et al. Neuroinflammation and oxidative stress in diabetic neuropathy:futuristic strategies based on these targets[J]. Int J Endocrinol, 2014, 2014(1):674987. [5] Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome:Immune-inflammatory features as possible cardiovascular markers in diabetes[J]. WorldJ Orthop, 2015, 6(1):62-76. [6] Lane JT. The role of retinoids in the induction of nerve growth factor:a potential treatment for diabetic neuropathy[J]. Transl Res,2014, 164(3):193-195. [7] Lupachyk S, Watcho P, Stavnllchuk R, et al. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy[J]. Diabetes, 2013, 62(3):944-952. [8] 杨欢,郑小兰,徐国海,等.电针治疗糖尿病神经病理性疼痛机制的研究进展[J].北京:中国疼痛医学杂志,2015,21(11):855-858. [9] 郭义,方剑乔.实验针灸学[M]. 北京:中国中医药出版社, 2012:46-49. [10] Yangihashi S,Kamijo M,Watanabe K.Reduced mychanted fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats[J].Am J Pathol,1990,136(6):1363-1373. [11] Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration[J]. Cell Calcium, 2005, 38(3/4):409-415. [12] Liu H,Qian J,Wang F.Expression of two endoplasmic reticulum stress markers,GRP78 and GADD153,in rats retinal detachment model and its implication[J].Eye(Lond),2010,24(1):137. [13] Lupachyk S, Watcho P, Stavniichuk R, et al. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy[J]. Diabetes, 2013,62(3):944-952. [14] Yang GH, Li S, Pestka JJ. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol)[J]. Toxicol Appl Pharmacol, 2000, 162(3):207-217. [15] Hayashi T, Saito A, Okuno S, et al. Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death[J]. J Cereb Blood Flow Metab, 2003, 23(8):949-961. [16] Oida Y, Izuta H, Oyagi A, et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil[J]. Brain Res, 2008, 1208:217-224. [17] Reddy RK,Mao C,Baumeister P,et al.Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors:role of ATP binding site in suppression of caspase-7 activation[J]. Biol Chem,2003,278(23):20915-20924. [18] Ermakova SP, Kang BS, Choi BY, et al. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78[J]. Cancer Res, 2006,66(18):9260-9269. [19] Ranganathan AC, Zhang L, Adam AP, et al. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells[J]. Cancer Res, 2006, 66(3):1702-1711. [20] 陈晓蕾,贾农,柯亭羽,等.2型糖尿病合并亚临床甲状腺功能减低与肾脏损害相关分析[J].中国实用内科杂志,2018,38(1):65-68. |